ALBINO – Effect of ALLopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome

The ALBINO study (Effect of ALLopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome), funded by the European Union, aims at showing the efficacy of the drug “allopurinol”. For this purpose, 900 newborns who have suffered from oxygen deficiency during birth will be examined. Even in large hospitals there are fewer than five such babies per year. That is why it is necessary to conduct an extensive multicenter international study in order to recruit the patient number.

• Researcher: Jose Antonio Hurtado Suazo
• Group: MP16-INTESTINAL IMMUNOMODULATION
• Centre: University Hospital Virgin of the Snows
• Role in the project: Outsourced
• Duration: 2017-2022

Project website: https://www.albino-study.eu/index.php